Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
New Post
One Size Fits All: DOJ’s First Department-Wide Corporate Enforcement Policy
March 13, 2026
Insight
New Post
Los Angeles lawyer gets 87 months in prison for role in money laundering and bribery scheme
February 25, 2026
News Alert